Many in Washington believe Pete Hegseth’s future leading the Defense Department can be counted in days.

© Photo Illustration by Damon Winter/The New York Times

A looming impeachment push could put President Trump’s polarizing defense secretary in a standoff with Democrats and Republicans.

© Haiyun Jiang/The New York Times

In a new video, the defense secretary vowed to “finish what we have started.” Some Republicans say the Iran war was a big factor in their party’s midterm losses.

© Haiyun Jiang/The New York Times

The Pentagon said that the decision by Pete Hegseth to widen the patrols was made on Oct. 29, just before a landslide defeat for Republicans in the midterm elections.

© Alex Kent/The New York Times

The midterm results laid bare the deep unpopularity of the war of choice that President Trump started and is now struggling to end.

© Toby Shepheard/Reuters

The midterm results laid bare the deep unpopularity of the war of choice that President Trump started and is now struggling to end.

© Toby Shepheard/Reuters

A federal judge’s ruling on the side of the small defense contractor was a rarity, as most company protests against government bidding decisions do not prevail.

© Mike Kai Chen for The New York Times

The pontiff draws on his missionary background for a show of fortitude.

© Pool photo by Teresa Suarez

Up to a quarter of active-duty Army members could receive a low testosterone result from mandatory military screening, despite the true prevalence of the condition likely being a tiny fraction of that figure, according to a study published Thursday in JAMA.

The finding adds to concerns that the mandatory screening announced by Defense Secretary Pete Hegseth in July will lead to a cascade of unnecessary medical evaluations for military members. Those evaluations could result in inappropriate testing, inaccurate results and diagnoses, and overtreatment that could cause harm, including infertility. Medical experts, including the Endocrine Society and the American Urological Association (AUA), have recommended against blanket screenings for these reasons. Still, the Pentagon has moved forward with the plans, releasing clinical guidance in September.

The JAMA study highlights the reasons why testosterone levels are not measured in men without symptoms—and also offers a glimpse of how many Army members could become ensnared in the clinically dubious screenings.

Read full article

Comments

© Getty | Win McNamee

The Pentagon had “ample support for its conclusion” that the A.I. company’s products could pose a national security risk, according to a Washington appeals court.

© Manuel Orbegozo for The New York Times